L85.3
Conditions
Interventions
Group 1: Patients with dry skin, with and without dermatoses, were to be treated with the cosmetic cream Imlan for two weeks as monotherapy. Only those patients were recruited in whom monotherapy wit
Sponsors
Birken GmbH
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: • dry, itchy skin • age = 18 years • Pruritus intensity above NRS=3 (numercal rating scale 0-10)
Exclusion criteria
Exclusion criteria: • Pregnancy, breast-feeding • Drug consumption, drug abuse • Active psychosomatic and psychiatric disorders • Known active malignant underlying disease • Topical application of tacrolimus, pimecrolimus, steroids or capsaicin in the 2 weeks immediately preceding the start of the study • Intake of antihistamines, steroids, cyclosporin A or other immunosuppressants, naltrexon, UV therapy in the 2 weeks immediately preceding the start of the study • Previous studies within the past 4 weeks
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change of the dry skin due to the cosmetical characteristics (patient documentation questionnaire, baseline, week 2) | — |
Secondary
| Measure | Time frame |
|---|---|
| Change in patienten-reported documentation via questionnaire (baseline, week 2): Frequency of application, Side effects, Sensory assessment: course of pruritus, skin irritation and burning, Patient benefits (PBI-P), Quality of life (DLQI). Change in Physician obtained documentation of pruritus intensity and scratch lesions (via routine documentation at baseline, week 2) | — |
Countries
Germany
Outcome results
None listed